MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,121 Cr | ₹2,413 Cr | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr |
What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,121 Cr |
| Mar2025 | ₹2,413 Cr |
| Mar2024 | ₹2,152 Cr |
| Mar2023 | ₹1,813 Cr |
| Mar2022 | ₹920 Cr |
How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,121 Cr | 29.33 | |
| Mar2025 | ₹2,413 Cr | 12.12 | |
| Mar2024 | ₹2,152 Cr | 18.70 | |
| Mar2023 | ₹1,813 Cr | 97.15 | |
| Mar2022 | ₹920 Cr | - | |
Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹99,863.4 Cr | -0.9% | -5.1% | -5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.9% |
-5.1% |
-5% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses